Insider · CIK 0001817230

Tjian Robert

Reports to the SEC for 1 company · SAN FRANCISCO, CA

Transactions

Companies

Filings

CIK

0001817230

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-28	NRIXNurix Therapeutics, Inc.C Conversion	Director	CConversion	+41.7K sh	—	—	74,999
2020-07-28	NRIXNurix Therapeutics, Inc.C Conversion	Director	CConversion	+50K sh	—	—	124,999
2020-07-28	NRIXNurix Therapeutics, Inc. · Series A-2 Preferred StockC Conversion	Director	CConversion	−41.7K sh	—	—	0
2020-07-28	NRIXNurix Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−50K sh	—	—	0

C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205

SAN FRANCISCO, CA, 94158